UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism Journal article
Cancer Letters, 2015,Volume: 362,Issue: 1,Page: 106-115
Authors:  Shim J.S.;  Li R.-J.;  Lv J.;  Head S.A.;  Yang E.J.;  Liu J.O.
Favorite |  | TC[WOS]:14 TC[Scopus]:16 | Submit date:2019/01/15
Angiogenesis  Cholesterol Trafficking  Selective Estrogen Receptor Modulator  Tamoxifen  
A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptor Journal article
Cancer Letters, 2014,Volume: 346,Issue: 1,Page: 94-103
Authors:  Yu T.;  Zhou Z.;  Mu Y.;  De Lima Lopes G.;  Luo K.Q.
Favorite |  | TC[WOS]:24 TC[Scopus]:26 | Submit date:2018/12/18
Acetyltanshinone Iia  Anti-breast Cancer Agent  Fulvestrant  Oestrogen Receptor  Tamoxifen  
Furanodiene enhances tamoxifen‐induced growth inhibitory activity of ERa‐positive breast cancer cells in a PPARγ independent manner Journal article
Journal of Cellular Biochemistry, 2012,Volume: 113,Issue: 8,Page: 2643
Authors:  Zhong Z.-F.;  Li Y.-B.;  Wang S.-P.;  Tan W.;  Chen X.-P.;  Chen M.-W.;  Wang Y.-T.
Favorite |  | TC[WOS]:24 TC[Scopus]:25 | Submit date:2018/10/31
Apoptosis  Breast Cancer  Cell Cycle  Furanodiene  Pparγ  Tamoxifen  
Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: Proteomic characterization Journal article
Experimental Cell Research, 2007,Volume: 313,Issue: 2,Page: 357-368
Authors:  Wang Y.;  He Q.-Y.;  Chen H.;  Chiu J.-F.
Favorite |  | TC[WOS]:22 TC[Scopus]:25 | Submit date:2019/01/16
Apoptosis  Breast Cancer  Proteomics  Retinoic Acid  Tamoxifen  Tgfβ